| Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium (NCT03476798) | University of Oklahoma | 2018-06-29 |
| A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) (NCT03439670) | ReveraGen BioPharma, Inc. | 2018-06-29 |
| Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161) (NCT03407170) | Merck Sharp & Dohme LLC | 2018-06-28 |
| Compare Neoadjuvant Chemotherapy of DOS Versus SOX in Locally Advanced Gastric Adenocarcinoma. (NCT03691454) | Peking University | 2018-06-28 |
| Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence (NCT03566290) | GTx | 2018-06-28 |
| Fatty Acid Supplementation in Children With ASD (NCT03550209) | Sarah Keim | 2018-06-28 |
| Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma (NCT02782715) | University of Wisconsin, Madison | 2018-06-28 |
| Intra-oral Treatment of OLP With Rivelin®-CLO Patches (NCT03592342) | Dermtreat | 2018-06-28 |
| Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease (NCT03492840) | Raziel Therapeutics Ltd. | 2018-06-28 |
| Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer (NCT03521570) | Emory University | 2018-06-28 |
| ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure (NCT03416270) | University Health Network, Toronto | 2018-06-28 |
| Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal (NCT04112160) | University of Texas Southwestern Medical Center | 2018-06-28 |
| Long Term Effects on Skin Hyper Pigmentation With and Without Mesenchymal Stem Cell Enriched Adipose Tissue Grafting for "Contour Deformities With Pigmentary Changes on Face" (NCT03564808) | King Edward Medical University | 2018-06-27 |
| CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) (NCT03504488) | BioAtla, Inc. | 2018-06-27 |
| A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer (NCT03560856) | Assistance Publique - Hôpitaux de Paris | 2018-06-27 |
| Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)] (NCT03504163) | Memorial Sloan Kettering Cancer Center | 2018-06-27 |
| Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma (NCT03488667) | University of Kansas Medical Center | 2018-06-27 |
| Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases (NCT02971501) | National Cancer Institute (NCI) | 2018-06-27 |
| Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia (NCT03576547) | M.D. Anderson Cancer Center | 2018-06-26 |
| A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus (NCT03586830) | Janssen Research & Development, LLC | 2018-06-26 |
| Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma (NCT03502746) | Arkadiusz Z. Dudek, MD | 2018-06-26 |
| A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC (NCT03547999) | Patrick Boland | 2018-06-26 |
| TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion) (NCT03555032) | Royal Marsden NHS Foundation Trust | 2018-06-26 |
| A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease (NCT03598699) | AxeroVision, Inc. | 2018-06-26 |
| A Study to Investigate a New Treatment in Patients With Parkinson's Disease (NCT03407378) | Tools4Patient | 2018-06-26 |
| Determining the Impact of Penicillin in Latent RHD: The GOAL Trial (NCT03346525) | Children's National Research Institute | 2018-06-26 |
| Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL) (NCT03501550) | Cocrystal Pharma, Inc. | 2018-06-26 |
| First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma (NCT03625037) | Genmab | 2018-06-26 |
| APRIL (AbatacePt in Rheumatoid Arthritis-ILD) (NCT03084419) | Cambridge University Hospitals NHS Foundation Trust | 2018-06-26 |
| Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer (NCT03480230) | Arafat Tfayli | 2018-06-26 |
| Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure (NCT03532009) | AstraZeneca | 2018-06-26 |
| Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris (NCT03573518) | Botanix Pharmaceuticals | 2018-06-26 |
| Dextromethorphan in Fibromyalgia (NCT03538054) | University of Alabama at Birmingham | 2018-06-26 |
| A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E Mutation (NCT03585686) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2018-06-26 |
| Two Chemotherapy Regimens Plus or Minus Bevacizumab (NCT03351296) | Gustave Roussy, Cancer Campus, Grand Paris | 2018-06-26 |
| A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression (NCT03543410) | Sumitomo Pharma America, Inc. | 2018-06-26 |
| Effects of Probiotics in Preventing Oral Mucositis (NCT03552458) | National University Hospital, Singapore | 2018-06-26 |
| The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma (NCT04205201) | Chittagong Medical College | 2018-06-25 |
| Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection (NCT03487848) | Bristol-Myers Squibb | 2018-06-25 |
| Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations (NCT03243019) | University Hospital, Lille | 2018-06-25 |
| Hyperbaric Oxygen Brain Injury Treatment Trial (NCT02407028) | Gaylan Rockswold | 2018-06-25 |
| A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC (NCT03876925) | Sunshine Lake Pharma Co., Ltd. | 2018-06-25 |
| Vedolizumab Induction May Prevent Celiac Enteritis (NCT02929316) | AGA Clinical Research Associates, LLC | 2018-06-25 |
| Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors (NCT03485209) | Seagen, a wholly owned subsidiary of Pfizer | 2018-06-25 |
| PRO 140 in Treatment-Experienced HIV-1 Subjects (NCT03902522) | CytoDyn, Inc. | 2018-06-25 |
| QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease (NCT03472690) | Qu Biologics Inc. | 2018-06-25 |
| Chloroprocaine Spinal for Outpatient Knee Surgery (NCT03365752) | Hospital for Special Surgery, New York | 2018-06-24 |
| Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test (NCT03864978) | Alfasigma S.p.A. | 2018-06-22 |
| Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer (NCT03458247) | Assistance Publique - Hôpitaux de Paris | 2018-06-22 |
| Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China (NCT03575065) | BeiGene | 2018-06-22 |
| A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components (NCT03562624) | Bayer | 2018-06-22 |
| Prostate Cancer Patient Management With 18F-DCFPyL PET/CT (NCT03459820) | Sir Mortimer B. Davis - Jewish General Hospital | 2018-06-22 |
| The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer (NCT03414658) | Adrienne G. Waks | 2018-06-21 |
| Acellular Adipose Tissue (AAT) for Soft Tissue Reconstruction (NCT03544632) | Johns Hopkins University | 2018-06-21 |
| Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma (NCT03470805) | Grupo Español de Investigación en Cáncer de Ovario | 2018-06-21 |
| Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis (NCT03598036) | Aurinia Pharmaceuticals Inc. | 2018-06-21 |
| Lisdexamfetamine for Adults With Bulimia Nervosa (NCT03397446) | Aaron Keshen | 2018-06-21 |
| MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study. (NCT03611556) | MedImmune LLC | 2018-06-21 |
| Afatinib in Locally Advanced and Metastatic Chordoma (NCT03083678) | Leiden University Medical Center | 2018-06-21 |
| Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma (NCT03436654) | Memorial Sloan Kettering Cancer Center | 2018-06-21 |
| A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer (NCT03535727) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-06-21 |
| Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial (NCT03322995) | Medical College of Wisconsin | 2018-06-21 |
| Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients (NCT03571620) | Qurient Co., Ltd. | 2018-06-21 |
| Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE) (NCT06304064) | Capricor Inc. | 2018-06-21 |
| A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS) (NCT03506425) | Richard Bedlack, M.D., Ph.D. | 2018-06-21 |
| DENdritic Cell Immunotherapy for Mesothelioma (NCT03610360) | Amphera BV | 2018-06-21 |
| Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F) (NCT05490771) | National Cancer Institute (NCI) | 2018-06-20 |
| Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (NCT03475212) | Pediatric Transplantation & Cellular Therapy Consortium | 2018-06-20 |
| Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours (NCT03518606) | UNICANCER | 2018-06-20 |
| A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471 (NCT03459443) | Alexion Pharmaceuticals, Inc. | 2018-06-20 |
| A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine (NCT03560245) | Neurotrope Bioscience, Inc. | 2018-06-20 |
| A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） Patient (NCT03557099) | Jiangsu HengRui Medicine Co., Ltd. | 2018-06-20 |
| Furosemide for Accelerated Recovery of Blood Pressure Postpartum (NCT03556761) | University of Pennsylvania | 2018-06-20 |
| Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma (NCT03400917) | Aivita Biomedical, Inc. | 2018-06-20 |
| Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP (NCT03562832) | Allarity Therapeutics | 2018-06-20 |
| HEAL STUDY (Hepatic Encephalopathy and Albumin Study) (NCT03585257) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2018-06-20 |
| AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm (NCT03453489) | Barbara Ann Karmanos Cancer Institute | 2018-06-20 |
| A Study of Bermekimab in Patients With Hidradenitis Suppurativa (NCT03512275) | Janssen Research & Development, LLC | 2018-06-20 |
| Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial (NCT03371719) | NRG Oncology | 2018-06-20 |
| Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis (NCT04278040) | Federal State Budgetary Institution, Pulmonology Scientific Research Institute | 2018-06-20 |
| Pembrolizumab, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma (NCT03506360) | Mayo Clinic | 2018-06-19 |
| A Study to Assess the Safety and Tolerability of SOBI003 in Pediatric MPS IIIA Patients (NCT03423186) | Swedish Orphan Biovitrum | 2018-06-19 |
| Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis (NCT03533751) | AnaptysBio, Inc. | 2018-06-19 |
| Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma (NCT03397186) | Fred Hutchinson Cancer Center | 2018-06-19 |
| Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer (NCT03585998) | Samsung Medical Center | 2018-06-19 |
| A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma (NCT03294083) | SillaJen, Inc. | 2018-06-19 |
| A Study of PTS100 in Primary HCC Patients (NCT03447951) | Gongwin Biopharm Co., Ltd. | 2018-06-19 |
| Oat Beta-glucan as a Supplement in Chilean Type 2 Diabetics (NCT04299763) | Centro de Estudios en Alimentación y Nutrición, Chile | 2018-06-19 |
| Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15 (NCT03554772) | Dr. Reddy's Laboratories Limited | 2018-06-19 |
| Dysport in Hallux Abducto Valgus (HAV) Phase IIa (NCT03569098) | Ipsen | 2018-06-19 |
| Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation (NCT03433235) | Jong Sung Kim | 2018-06-19 |
| A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis (NCT03423121) | Johns Hopkins University | 2018-06-19 |
| Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer (NCT03394885) | Duke University | 2018-06-19 |
| A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV) (NCT03577171) | Assembly Biosciences | 2018-06-19 |
| Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma (NCT03502148) | Privo Technologies | 2018-06-19 |
| The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer (NCT03444376) | Genexine, Inc. | 2018-06-19 |
| A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis (NCT03486899) | Bristol-Myers Squibb | 2018-06-19 |
| Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer (NCT03463460) | Dwight Owen | 2018-06-19 |
| Denosumab in Subjects With Giant Cell Rich Tumors of Bone (NCT03605199) | Leiden University Medical Center | 2018-06-18 |
| A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody (NCT03525678) | GlaxoSmithKline | 2018-06-18 |